Paramyxoviridae infectious disease
MONDO:0005896Infections with viruses of the family paramyxoviridae. This includes morbillivirus infections; respirovirus infections; pneumovirus infections; henipavirus infections; avulavirus infections; and rubulavirus infections.
Also known as: Paramyxoviridae caused disease or disorder, Paramyxoviridae disease or disorder
31 clinical trials for this condition and its sub-types, 6 tagged with Paramyxoviridae infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Paramyxoviridae infectious disease
-
Morbillivirus infectious disease 0 trials · 16 incl. sub-types
1 sub-type
- Measles 16 trials
-
Mumps infectious disease 10 trials
1 sub-type
- Congenital mumps 0 trials
-
Parainfluenza infectious disease 6 trials · 9 incl. sub-types
4 sub-types
-
Respirovirus infectious disease 0 trials · 4 incl. sub-types
2 sub-types
-
Henipavirus infectious disease 2 trials
1 sub-type
- Nipah virus disease 2 trials
-
Avulavirus infectious disease 0 trials
Most studied deeper sub-types
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
Vaccine CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Phase 1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
New combo vaccine targets flu, RSV, and more in early trial
Vaccine CompletedThis early-stage study tested the safety and immune response of new vaccines that combine protection against flu, RSV, hMPV, and PIV3 in healthy adults aged 18 to 49. Participants received a single shot of one of several vaccine formulas. The goal was to see if these combination …
Phase 1 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC